There have been many studies of blood flow in DR. However, results are potentially confounded by differences in measurement location (e.g., arteriole, venule, or capillary; papillary, macular; retina, and choroid), disease severity (e.g., NPDR and PDR), disease type (e.g., types 1 and 2), object of measurement (e.g., erythrocyte, leukocyte, and plasma bolus), or even disease model (e.g., rat, monkey and human). Considering only results from human subjects, it appears that blood flow in arteries and veins is decreased before the onset of DR
32 –34 and increased during NPDR.
34 –37 Perifoveal capillary velocity was found to be decreased in patients with diabetes,
9 consistent with the data in this study; however, papillomacular capillary blood flow was found to be increased in patients with type 2 diabetes but no DR,
8 suggesting that changes in the blood flow are heterogeneous. Finally, studies investigating the pulsatility of blood in choroidal vessels have found increases in pulsatility in the later stages of DR (severe NPDR, PDR),
38,39 but the results are inconsistent in the earlier stages, with decreases,
38 no change,
39 and increases
40 shown. In our study, leukocyte speed was 14% lower and the pulsatility index 25% higher. We identified capillary segments using AV channels to perform leukocyte speed measurements in the same corresponding location of the parafoveal capillary network in all subjects; furthermore, measured speeds were normalized for the cardiac cycle. The average heart rate, which was simultaneously recorded during the acquisition of every AOSLO video was similar in both groups (66.4 ± 11.7 for T2DM_NoDR and 64.7 ± 9.4 for controls, reported as mean beats per minute ± SD). Increased AV channel tortuosity is consistent with decreased leukocyte speed, since leukocytes must deform to travel through small capillaries in single file,
41 and any increase in tortuosity is likely to require additional deformations for leukocyte passage. In addition, the decreased leukocyte speed is consistent with the increased rigidity of diabetic leukocytes.
42 Although the results of statistical testing for these hemodynamic measures were not significant (i.e., inconclusive), such metrics may still be of clinical importance.